-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, JECBEEx5ywGeEpvq1fE31MWwGd+Z5y8fFIy9Y4sV+B4WFs9Tg532f+2mbe0jIdLM zpDrWw7fxKIQvtogEvdc1g== 0001181431-08-039160.txt : 20080617 0001181431-08-039160.hdr.sgml : 20080617 20080617142737 ACCESSION NUMBER: 0001181431-08-039160 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20080613 FILED AS OF DATE: 20080617 DATE AS OF CHANGE: 20080617 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Chelsea Therapeutics International, Ltd. CENTRAL INDEX KEY: 0001333763 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 203174202 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 13950 BALLANTYNE CORPORATE PLACE STREET 2: UNIT 325 CITY: CHARLOTTE STATE: NC ZIP: 28277 BUSINESS PHONE: 704-341-1516 MAIL ADDRESS: STREET 1: 13950 BALLANTYNE CORPORATE PLACE STREET 2: UNIT 325 CITY: CHARLOTTE STATE: NC ZIP: 28277 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Oliveto Joseph CENTRAL INDEX KEY: 0001437782 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-51462 FILM NUMBER: 08902860 BUSINESS ADDRESS: BUSINESS PHONE: 704-341-1516 MAIL ADDRESS: STREET 1: C/O CHELSEA THERAPEUTICS, INC. STREET 2: 3530 TORINGDON WAY, SUITE 200 CITY: CHARLOTTE STATE: NC ZIP: 28277 3 1 rrd211051.xml FORM 3 X0202 3 2008-06-13 0 0001333763 Chelsea Therapeutics International, Ltd. CHTP 0001437782 Oliveto Joseph 3530 TORINGDON WAY SUITE 200 CHARLOTTE NC 28277 0 1 0 0 Vice President of Operations No securities are beneficially owned 0 D /s/ Jeffrey M. Smith, Attorney-in-Fact 2008-06-17 EX-24. 2 rrd188797_212913.htm POWER OF ATTORNEY rrd188797_212913.html

	POWER OF ATTORNEY


	Known all by these presents that the undersigned hereby constitutes and appoints each of
Simon Pedder, J. Nick Riehle, Donald R. Reynolds, Jeffrey M. Smith and S. Halle Vakani, and
each of them acting alone, signing singly, the undersigned's true and lawful attorney-in-fact to:
(1) execute for and on behalf of the undersigned, in the undersigned's capacity as an officer,
director and/or 10% or more stockholder of Chelsea Therapeutics International, Ltd. (the
"Company"), Forms ID, 3, 4 and 5 and Schedules 13D or 13G (and any amendments thereto)
under Section 13(d) and 16(a) of the Securities Exchange Act of 1934, as amended (the "1934
Act") in accordance with the 1934 Act, and the rules promulgated thereunder; (2) do and perform
any and all acts for and on behalf of the undersigned which may be necessary or desirable to
complete and execute any such Form or Schedule (and any amendments thereto) and to file
timely such Form or Schedule with the United States Securities and Exchange Commission and
any stock exchange or similar authority; and (3) take any other action of any type whatsoever in
connection with the foregoing which in the opinion of such attorney-in-fact may be of benefit to,
in the best interest of, or legally required by, the undersigned, it being understood that the
documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power
of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-
fact may approve in such attorney-in-fact's discretion.

	The undersigned hereby grants to each such attorney-in-fact full power and authority to
do and perform any and every act and thing whatsoever requisite, necessary or proper to be done
in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes
as the undersigned might or could do if personally present, with full power of substitution or
revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-
fact's substitute or substitutes, shall lawfully do or cause to be done by virtue of this power of
attorney and the rights and powers herein granted.  The undersigned acknowledges that the
foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not
assuming, nor is the Company assuming, any of the undersigned's responsibilities to comply with
Section 13(d) or 16(a) of the 1934 Act.

	This Power of Attorney shall remain in full force and effect until the undersigned is no
longer required to file such Forms or Schedules with respect to the undersigned's holdings of and
transactions in securities issued by the Company, unless earlier revoked by the undersigned in a
signed writing delivered to each of the foregoing attorneys-in-fact.

	IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be
executed as of this 12th day of June 2008.


						/s/ Joseph Oliveto

						Print Name:  Joseph Oliveto

17078.55 539084 v1
17078.5-523513 1

-----END PRIVACY-ENHANCED MESSAGE-----